LC
KRRO icon

Lindbrook Capital’s Korro Bio KRRO Stock Holding History

Lindbrook Capital’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31
Closed -$1.18K – 2870
2024
Q4 		$1.18K Sell
31
-14
-31% -$719 ﹤0.01% 2451
2024
Q3 		$1.5K Buy
+45
New +$1.89K ﹤0.01% 2416

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lindbrook Capital's KRRO Position: Q1 2025 in Review

Lindbrook Capital sold out of Korro Bio (KRRO) in Q1 2025, closing a stake of 31 shares — an estimated $1.18K sold.

Lindbrook Capital first reported a position in KRRO in Q3 2024 and held it in 2 quarters. The position peaked at $1.5K in Q3 2024. 75 funds tracked by Wall St. Rank hold KRRO as of Q1 2025.

  • Lindbrook Capital reported no remaining Korro Bio position as of Q1 2025 after selling out during the quarter.
  • Lindbrook Capital sold 31 Korro Bio shares in Q1 2025, an estimated $1.18K.
  • Lindbrook Capital first reported a position in Korro Bio in Q3 2024 and held it in 2 quarters.
  • Lindbrook Capital's Korro Bio position peaked at $1.5K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Korro Bio as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.